JBC PeproTech; Our Business is Cytokines!

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


A more recent version of this article appeared on May 16, 2008
This Article
Right arrow Full Text (Accepted Manuscript)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
283/20/14032    most recent
M800859200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Google Scholar
Right arrow Articles by Kim, K.-J.
Right arrow Articles by Kang, B. S.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kim, K.-J.
Right arrow Articles by Kang, B. S.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Papers In Press, published online ahead of print March 14, 2008
J. Biol. Chem, 10.1074/jbc.M800859200
Submitted on February 1, 2008
Revised on March 11, 2008
Accepted on March 13, 2008

Determination of three dimensional structure and residues of novel tumor suppressor, AIMP3/p18, required for the interaction with ATM

Kyung-Jin Kim, Min Chul Park, So Jung Choi, Young Sun Oh, Eung-Chil Choi, Hyo Je Cho, Myung Hee Kim, Soo-Hyun Kim, Dong Wook Kim, Sunghoon Kim, and Beom Sik Kang

College of Pharmacy, Center for ARS Network, Seoul 151-742

Corresponding Author: sungkim{at}snu.ac.kr

Although AIMP3/p18 is normally associated with multi-tRNA synthetase complex via specific interaction with methionyl-tRNA synthetase, it also works as a tumor suppressor via the stimulatory interaction with ATM, the upstream kinase of p53 in response to DNA damage. To understand its molecular interaction and working mechanism, we determined the crystal structure of AIMP3 at 2.0 Å resolution and the potential site involved in its interaction with ATM. AIMP3 contains the two distinct domains linked by 7 aa (K57-S63) forming 310 helix. The 56aa N-terminal domain consists of 2 helices to which three antiparallel -strands are inserted and 111 aa C-terminal domain contains a bundle of five helices (T64-Y152) with a following coiled region (P153-L169). Structural analyses unveiled homologous proteins such as yeast glutamyl-tRNA synthetase, Arc1p, EF1B and glutathione S-transferase and suggested two potential molecular interaction sites. Among them, mutations at the C-terminal putative binding site abolished the interaction of AIMP3 with ATM, but not with methionyl-tRNA synthetase . These mutants also have lost their ability to activate p53. Thus, this work suggests that AIMP3 would bind to two different target proteins via different sites and residues critical for its tumor suppressive activity via ATM.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2008 by the American Society for Biochemistry and Molecular Biology.